Compare EVGOW & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVGOW | XGN |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | United States |
| Employees | 376 | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 71.2M |
| IPO Year | N/A | 2014 |
| Metric | EVGOW | XGN |
|---|---|---|
| Price | $0.01 | $3.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.86 |
| AVG Volume (30 Days) | 154.5K | ★ 205.8K |
| Earning Date | 03-07-2025 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $239,306,000.00 | N/A |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 73.08 | N/A |
| 52 Week Low | $0.00 | $2.59 |
| 52 Week High | $0.33 | $12.23 |
| Indicator | EVGOW | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.72 | 73.74 |
| Support Level | $0.00 | $2.61 |
| Resistance Level | $0.03 | $3.89 |
| Average True Range (ATR) | 0.01 | 0.23 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 41.40 | 93.65 |
EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.